KumaraswamySivakumarMD

PubMed

• 6 citations
  Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02).
  Barry J Byrne, Benedikt Schoser, Priya S Kishnani, Drago Bratkovic, Paula R Clemens
  Journal of Neurology. 2024-04-01
• 2 citations
  Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
  James F Howard Jr, Saskia Bresch, Constantine Farmakidis, Miriam Freimer, Angela Genge
  Therapeutic Advances in Neurological Disorders. 2024-01-01
• 42 citations
  Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
  James F Howard Jr, Saskia Bresch, Angela Genge, Channa Hewamadduma, John Hinton
  The Lancet. Neurology. 2023-05-01

Journal Articles

• Exome sequencing identifies titin mutations causing hereditary myopathy with early respiratory failure (HMERF) in families of diverse ethnic origins  
  Toro C, Olive M, Dalakas M, Sivakumar K, Bilbao JM, Tyndel F, Vidal N, Farrero E, Sambuughin N, Goldfarb LG, BMC Neurol, 1/1/2013
• Autosomal recessive spastic ataxia of Charlevoix-Saguenay: compound heterozygotes for nonsense mutations of the SACS gene  
  Narayanan V, Rice SG, Olfers SS, Sivakumar K, J Child Neurol, 1/1/2011
• Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect  
  Pioro EP, Brooks BR, Cummings J, Schiffer R, Thisted RA, Wynn D, Hepner A, Kaye R; Safety, Ann Neurol, 1/1/2010
• Histopathological progression and a novel mutation in a child with nemaline myopathy  
  Ladha S, Coons S, Johnsen S, Sambuughin N, McWilliams S, Sivakumar K, J child neurol, 7/1/2008
• Painful brachial plexopathies in SEPT9 mutations: adverse outcome related to co-morbid states  
  Hoque R, Schwendimann RN, Kelley R, Bien-Willner R, Sivakumar K, J Clincial neuromuscular diseases, 1/1/2008
• Solitary pyogenic abscess of the medulla oblongata: survival after aspiration and antibiotics  
  Kniss M, Sivakumar K, Neurology, 1/1/2006
• Autoimmune hearing loss in chronic inflammatory demyelinating polyneuropathy  
  Sivakumar K, Fife T, Neurology, 1/1/2005
• Guillain-Barre Syndrome  
  Sivakumar K, IG News, 4/1/2004
• Charcot-Marie-Tooth disease: extensive cranial nerve involvement on CT and MR imaging  
  Aho TR, Wallace RC, Pitt AM, Sivakumar K, Am J Neuroradiol, 1/1/2004
• A controlled study of intravenous immunoglobulin combined with prednisone  
  Dalakas MC, Koffman BD, Fujii M, Spector S, Sivakumar K, Cupler E, Neurology, 1/1/2001
• Desmin myopathy: a distinct, distal-onset skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene  
  Dalakas MC, Park K, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG, N Engl J Med, 1/1/2000
• Novel exon 3B proteolipid protein gene mutation causing late-onset spastic paraplegia type 2 with variable penetrance in female family members  
  Sivakumar K, Sambuughin N, Selenge B, Nagle JW, Baasanjav D, Hudson LD, Goldfarb LG, Ann Neurol, 1/1/1999
• Autosomal dominant distal spinal muscular atrophy type V (dSMA V) and Charcot Marie Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a ...  
  Sambuughin N, Sivakumar K, Selenge B, Lee HS, Friedlich D, Baasanjav D, Dalakas MC, Goldfarb, J Neurol Sci, 1/1/1998
• HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies  
  Koffman BM, Sivakumar K, Simonis T, Stroncek D, Dalakas MC, J Neuroimmunol, 1/1/1998
• The post-polio syndrome: current concepts and treatment  
  Spector SA, Sivakumar K, Infectious Diseases in Medicine, 1/1/1997
• The efficacy of high-dose intravenous immunoglobulin in patients with inclusion body myositis  
  Dalakas MC, Sonies B, Dambrosia JM, Sekul EL, Cupler EJ, Sivakumar K, Neurology, 1/1/1997
• Is hereditary inclusion body myopathy a "familial prion disease"?  
  Cervenkova L, Sivakumar K, Nagle JW, Dalakas MC, Goldfarb LG, Ann Neurol, 1/1/1996
• Co-existence of diabetes and phosphofructokinase deficiency  
  Poretsky L, Rubio SI, Naha KK, Sivakumar K, Dalakas MC, Endocrine Practice, 1/1/1996
• Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuoles, abnormal mitochondria and absence of the common exon 5/intron 5 ...  
  Sivakumar K, Vasconcelos O, Goldfarb LG, Dalakas MC, Neurology, 1/1/1996
• Symptomatic epidural lipomatosis in a patient with pituitary Cushing's syndrome  
  Sivakumar K, Shienart C, Lidov M, Cohen B, Neurology, 1/1/1995
•  
  Sivakumar K, Cervenkova L, Dalakas MC, Leon-Monzon M, Isaacson SI, Nagle JW, Vasconcelos O, Goldfarb LG, Ann Neurol, 1/1/1995
• Study of Fatigue in muscles of patients with Post-Polio Syndrome by in vivo 31P Magnetic Resonance Spectroscopy: A metabolic cause for fatigue  
  Sivakumar K, Sinnwell T, Yildiz, McLaughlin A, Dalakas MC, Ann N Y Acad Sci, 1/1/1995
• Cellular localization of poliovirus in the spinal cord during acute poliomyelitis  
  Isaacson SH, Sivakumar K, Pomeroy K, Asher DM, Ramos-Alvarez M, Gibbs CJ Jr. Gajdusek DC, Dalakas MC, Ann N Y Acad Sci, 1/1/1995
• Autoimmune syndrome induced by omeprazole  
  Sivakumar K, Dalakas MC, Lancet, 1/1/1994
• Join now to see all

Abstracts/Posters

• Assessment of Mortality in Sporadic Inclusion Body Myositis: A Delphi Panel Technique
  Price M, Barghout V, Benveniste O, Christopher-Stine L, Corbett A, de Visser M, Hilton-Jones D, Kissel JT, Lloyd T, Lundberg I, Mastaglia F, Mozaffar T, Needham M, Sch..., American Academy of Neurology 66th Annual Meeting, 4/1/2014
• Progress in inflammatory myopathies
  Sivakumar K, Srilankan Association of Neurologist, 11/1/2013
• Treatment of sporadic Inclusion Body Myositis with an anti-activin receptor IIB antibody
  Amato A, Sivakumar K, Goyal N, David W, Barohn RJ, Salajegheh M, Laurent D, Praestgaard J, Trifilieff E, Trendelenburg A, Glass DJ, Roubenoff R, Tseng BS, Greenberg SA, MDA Conference, 1/1/2013
• A Novel Phase 2a Study Design to Investigate the Effect of AT2220 (duvoglustat HCl) on the Pharmacokinetics of Acid Alpha-Glucosidase in Subjects with Pompe Disease.
  Kishnani P., Tarnopolsky M., Sivakumar K., Byrne B., Goker-Alpan O., Guter K., Pervaiz M., Dasouki M., Levine T., Roberts M., Laforet P., Johnson F., Valenzano K., Loc..., World Muscle Society, 10/1/2012
• Some random thoughts on the neurology case conference series highlighted by patients with neuromuscular diseases
  Sivakumar K, The first neurology case conference, 7/1/2009
• CMT: the gene tests
  Sivakumar K, Expert’s lecture to local neurologists, The Phoenician, 3/1/2009
• Update in Neuromuscular diseases
  Sivakumar K, 34th Annual Barrow symposium, 3/1/2008
• Progress in ALS
  Sivakumar K, Grand Rounds – Neurology, University of Arizona College of Medicine, 11/1/2007
• Recent developments in neuromuscular diseases
  Sivakumar K, Grand rounds, Pediatric neurology St Joseph’s hospital Children’s center, 5/1/2007
• Shoulder and arm pain with gradual onset weakness
  Bodensteiner JB, Sivakumar K, Bien-Willner R, Journal of Clinical Neuromuscular Diseases, 1/1/2007
• A disorder with phenotypic features of both Charcot-Marie-Tooth disease type 2D (CMT-2D) and distal spinal muscular atrophy type V (dSMA-V) is associated with glycyl-t...
  LG Goldfarb, T Kyriakides, I Puls, GA Nicholson, B Funalot, A Antonellis, N Sambuughin, K Christodoulou, JL Beggs, E Zamba-Papanicolaou, V Ionasescu, MC Dalakas, ED Gr..., HUGO meeting, 5/1/2006
• Demyelinating neuropathies
  Sivakumar K, Grand rounds, Pediatric neurology St Joseph’s hospital Children’s center, 5/1/2005
• Disorders of the motor neuron
  Sivakumar K, Grand rounds, Pediatric neurology St Joseph’s hospital Children’s center, 11/1/2004
• Deafness and CMT disease associated with a novel four amino acid deletion in the PMP22 gene
  Sambuughin N, De Bantel A, McWilliams S, Sivakumar K, Sambuughin N, De Bantel A, McWilliams S, Sivakumar K and AAN annual meeting, 1/1/2003
• Desmin storage myopathies
  Sivakumar K, Grand rounds, Barrow Neurological Institute, 11/1/2002
• Progress report on molecular genetic research in neuromuscular diseases in Mongolia
  Sivakumar K, National Institutes of Health, 11/1/2002
• An update on neuromuscular junction disorders
  Sivakumar K, Annual neuroscience conference, Barrow Neurological Institute, 4/1/2002
• An update on Myopathies
  Sivakumar K, Annual neuroscience conference, Barrow Neurological Institute, 4/1/2002
• Comprehensive screening of the RYR1 gene by denaturing high-performance liquid chromatography
  McWilliams S, Nelson T , Cavender M, Goldfarb L, Sivakumar K, Sambuughin N, Am Soc Hum Genet, 1/1/2002
• An update on neuromuscular diseases
  Sivakumar K, Annual neuroscience conference, Barrow Neurological Institute, 4/1/2001
• An update in neuromuscular diseases
  Sivakumar K, Annual neuroscience conference, Barrow Neurological Institute, 4/1/2000
• Clinical Neurophysiology Workshop
  Sivakumar K, Annual neuroscience conference, Barrow Neurological Institute, 4/1/2000
• Inflammatory myopathies
  Sivakumar K, Annual neuroscience conference, Barrow Neurological Institute, 4/1/2000
• Malignant Hyperthermia Susceptibility (MHS) Family with new RYR1 mutation is likely linked to second MHS loci at 7q11-21
  Sambuughin N, Nelson T, Jankovic J, Sivakumar K and Goldfarb L, Malignant hyperthermia association meeting, 8/1/1999
• The nature of neurofilamentous accumulations in the so-called desmin storage myopathy
  Semino-Mora C, Sivakumar K, Goldfarb LG, Dalakas MC, Neurology and American Academy of Neurology Annual Sessions, 4/1/1999
• Join now to see all